المؤلفون: N. A. Chichagova, D. V. Gogolev, D. O. Kuzmin, A. N. Ananyev, A. A. Kutenkov, A. A. Galkin, T. B. Kapitulskaya, D. D. Fedotova, I. V. Ulyankina, O. N. Reznik, S. F. Bagnenko, Н. А. Чичагова, Д. В. Гоголев, Д. О. Кузьмин, А. Н. Ананьев, А. А. Кутенков, А. А. Галкин, Т. Б. Капитульская, Д. Д. Федотова, И. В. Ульянкина, О. Н. Резник, С. Ф. Багненко

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 25, № 4 (2023); 86-95 ; Вестник трансплантологии и искусственных органов; Том 25, № 4 (2023); 86-95 ; 2412-6160 ; 1995-1191

مصطلحات موضوعية: онкогематология, kidney transplantation, chronic kidney disease, immunohistochemistry, pathomorphology, oncohematology, трансплантация почки, хроническая болезнь почек, иммуногистохимия, патоморфология

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/1662/1543; https://journal.transpl.ru/vtio/article/downloadSuppFile/1662/1369; https://journal.transpl.ru/vtio/article/downloadSuppFile/1662/1372; https://journal.transpl.ru/vtio/article/downloadSuppFile/1662/1373; https://journal.transpl.ru/vtio/article/downloadSuppFile/1662/1374; https://journal.transpl.ru/vtio/article/downloadSuppFile/1662/1375; https://journal.transpl.ru/vtio/article/downloadSuppFile/1662/1376; https://journal.transpl.ru/vtio/article/downloadSuppFile/1662/1377; https://journal.transpl.ru/vtio/article/downloadSuppFile/1662/1378; https://journal.transpl.ru/vtio/article/downloadSuppFile/1662/1379; https://journal.transpl.ru/vtio/article/downloadSuppFile/1662/1380; https://journal.transpl.ru/vtio/article/downloadSuppFile/1662/1381; Данович ГМ. Трансплантация почки / Пер. с англ. под ред. Я.Г. Мойсюка. М.: ГЭОТАР-Медиа, 2014; 414.; Turshudzhyan A. Post-renal transplant malignancies: Opportunities for prevention and early screening. Cancer Treat Res Commun. 2021; 26: 100283. doi:10.1016/j.ctarc.2020.100283. Epub 2020 Dec 11. PMID: 33338850.; Katabathina VS, Menias CO, Tammisetti VS, Lubner MG, Kielar A, Shaaban A et al. Malignancy after Solid Organ Transplantation: Comprehensive Imaging Review. Radiographics. 2016 Sep-Oct; 36 (5): 1390–1407. doi:10.1148/rg.2016150175. PMID: 27618321.; Collett D, Mumford L, Banner NR, Neuberger J, Watson C. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant. 2010 Aug; 10 (8): 1889–1896. doi:10.1111/j.1600-6143.2010.03181.x. PMID: 20659094.; Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J et al. Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor. Case Rep Nephrol. 2015; 2015: 821346. doi:10.1155/2015/821346. Epub 2015 Apr 21. PMID: 25977825; PMCID: PMC4419238.; Wong RL, Ketcham M, Irwin T, Akilesh S, Zhang TY, Reyes JD et al. Donor-derived acute promyelocytic leukemia presenting as myeloid sarcoma in a transplanted kidney. Leukemia. 2020 Oct; 34 (10): 2776–2779. doi:10.1038/s41375-020-0903-0. Epub 2020 Jun 10. PMID: 32523036; PMCID: PMC7515823.; AlGhunaim M, AlSuwaida A, Zaidi SN, Kfoury H. First case report of acute myeloid sarcoma post renal transplant. Transplant Proc. 2014 Sep; 46 (7): 2411–2413. doi:10.1016/j.transproceed.2014.02.007. Epub 2014 Aug 20. PMID: 25150606.; Wu D, Lu X, Yan X, Gao R. Case report: Rare myeloid sarcoma development following renal transplantation with KRAS and DNMT3A gene mutations. Diagn Pathol. 2021 Aug 31; 16 (1): 82. doi:10.1186/s13000-02101141-z. PMID: 34465355; PMCID: PMC8406562.; Shen J, Du X, Diao X, Zhao L, Wang W, Yu Y, Luo H. Myeloid Sarcoma Presenting With Multiple Skin and Subcutaneous Mass Without Leukemic Manifestations After Renal Transplantation. Transplant Proc. 2015 Sep; 47 (7): 2227–2232. doi:10.1016/j.transproceed.2015.06.005. PMID: 26361685.; Williams T, Aljitawi OS, Moussa R, McHugh S, Dusing R, Abraha J, Yarlagadda SG. First case of donor transmitted non-leukemic promyelocytic sarcoma. Leuk Lymphoma. 2012 Dec; 53 (12): 2530–2534. doi:10.3109/10428194.2012.695360. Epub 2012 Jul 9. PMID: 22616573.; Савченко ВГ, Паровичникова ЕН. Острые лейкозы. Клиническая онкогематология: руководство для врачей / Под ред. М.А. Волковой. М.: Медицина, 2007: 409–502.; Solh M, Solomon S, Morris L, Holland K, Ba shey A. Extramedullary acute myelogenous leukemia. Blood Rev. 2016 Sep; 30 (5): 333–339. doi:10.1016/j.blre.2016.04.001. Epub 2016 Apr 8. PMID: 27094614.; Meis JM, Butler JJ, Osborne BM, Manning JT. Granulocytic sarcoma in nonleukemic patients. Cancer. 1986 Dec 15; 58 (12): 2697–2709. doi:10.1002/1097-0142(19861215)58:123.0.co;2-r. PMID: 3465429.; Antic D, Elezovic I, Milic N, Suvajdzic N, Vidovic A, Perunicic M et al. Is there a «gold» standard treatment for patients with isolated myeloid sarcoma? Biomed Pharmacother. 2013 Feb; 67 (1): 72–77. doi:10.1016/j.biopha.2012.10.014. Epub 2012 Nov 19. PMID: 23218987.; Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002 Mar 15; 94 (6): 1739–1746. doi:10.1002/cncr.10399. PMID: 11920536.; Mirza MK, Sukhanova M, Stölzel F, Onel K, Larson RA, Stock W et al. Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays. Leuk Res. 2014 Sep; 38 (9): 1091–1096. doi:10.1016/j.leukres.2014.05.004. Epub 2014 May 21. PMID: 25088808; PMCID: PMC4157130.; Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007 Feb; 21 (2): 340–350. doi:10.1038/sj.leu.2404491. Epub 2006 Dec 14. PMID: 17170724.; Avni B, Koren-Michowitz M. Myeloid sarcoma: current approach and therapeutic options. Ther Adv Hematol. 2011 Oct; 2 (5): 309–316. doi:10.1177/2040620711410774. PMID: 23556098; PMCID: PMC3573418.; https://journal.transpl.ru/vtio/article/view/1662

الاتاحة: https://journal.transpl.ru/vtio/article/view/1662
https://doi.org/10.15825/1995-1191-2023-4-86-95

المؤلفون: N. N. Gurgenidze, G. I. Popov, A. A. Kutenkov, A. A. Trushin, A. N. Zayceva, A. N. Shvetsov, I. V. Kazantsev, A. A. Zakharenko, Н. Н. Гургенидзе, Г. И. Попов, А. А. Кутенков, А. А. Трушин, А. Н. Зайцева, А. Н. Швецов, И. В. Казанцев, А. А. Захаренко

المساهمون: The study was performed without external funding, Исследование проведено без спонсорской поддержки

المصدر: Russian Journal of Pediatric Hematology and Oncology; Том 9, № 4 (2022); 53-63 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 9, № 4 (2022); 53-63 ; 2413-5496 ; 2311-1267

مصطلحات موضوعية: сосудистый имплант, ophthalmology, pediatric oncology, clinic and diagnosis of orbital pathology, myeloid leukemia, myeloid sarcoma, lymphomas, histiocytoses, гепатобластома, нефробластома, саркома, хирургическое лечение, пластика сосудов

وصف الملف: application/pdf

Relation: https://journal.nodgo.org/jour/article/view/883/780; Гургенидзе Н. Н. Радикальная резекция опухоли с пластикой сосуда ксеноперикардом как часть комплексной терапии у пациента со вторым рецидивом нефробластомы. Описание клинического случая и обзор литературы / Н. Н. Гурогенидзе [и др.] // Российский журнал детской гематологии и онкологии. – 2021. – 8 (2): 117–22. doi:10.21682/2311-1267-2021-8-2-117-122.; Etkin Y., Foley P. J., Wang G. J., Guzzo T. J., Roses R. E., Fraker D. L., Drebin J. A., Jackson B. M. Successful venous repair and reconstruction for oncologic resections. J Vasc Surg Venous Lymphat Disord. 2016; 4 (1): 57–63. doi:10.1016/j.jvsv.2015.05.003.; Ito F., Watanabe Y., Harada T., Ando H., Seo T., Kaneko K., Ishiguro Y., Sakurai T. Combined resection of abdominal aorta and inferior vena cava for retroperitoneal rhabdomyosarcoma invading the aortoiliac bifurcation. J Pediatr Surg. 1998; 33 (10): 1566–8. doi:10.1016/s0022-3468(98)90501-2.; Mavroudis C., Jonas R. A., Bove E. L. Personal glimpses into the evolution of truncus arteriosus repair. World J Pediatr Congenit Heart Surg. 2015; 6 (2): 226–38. doi:10.1177/2150135115572375.; Paran T. S., Corbally M. T., Gross-Rom E., Rutigliano D. N., Kayton M. L., La Quaglia M.P. Experience with aortic grafting during excision of large abdominal neuroblastomas in children. J Pediatr Surg. 2008; 43 (2): 335–40. doi:10.1016/j.jpedsurg.2007.10.045.; Szymczak M., Kaliciński P. J., Kowalewski G., Ciopiński M., Markiewicz-Kijewska M., Broniszczak D., Dembowska-Bagińska B., Kościesza A., Brzezińska-Rajszys G., Patkowski W., Stefanowicz M. Inferior Vena Cava and Venous Outfl ow Reconstruction in Living Donor Liver Transplantation in Children: A Single-Center Retrospective Study and Literature Review. Ann Transplant. 2021; 26: e926217. doi:10.12659/AOT.926217.; Psutka S. P., Leibovich B. C. Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma. Ther Adv Urol. 2015; 7 (4): 216–29. doi:10.1177/1756287215576443.; Cox S. G., Davidson A., Thomas J., Brooks A., Hewitson J., Numanoglu A., Millar A. J. W. Surgical management and outcomes of 12 cases of Wilms tumour with intracardiac extension from a single centre. Pediatr Surg Int. 2018; 34 (2): 227–35. doi:10.1007/s00383-017-4197-x.; Lalla A., Pritchard-Jonesb K., Walkerc J., Huttond C., Stevensd S., Azmye A., Carachi R. Wilms’ tumor with intracaval thrombus in the UK Children’s Cancer Study Group UKW3 trial. J Pediatr Surg. 2006; 41 (2): 382–7. doi:10.1016/j.jpedsurg.2005.11.016.; Grimaldi C., Bertocchini A., Crocoli A., de Ville de Goyet J., Castellano A., Serra A., Spada M., Inserra A. Caval replacement strategy in pediatric retroperitoneal tumors encasing the vena cava: a single-center experience and review of literature. J Pediatr Surg. 2019; 54 (3): 557–61. doi:10.1016/j.jpedsurg.2018.06.008.; Vlahova A., Konstantinov G., Antonova Z., Pahnev Y., Oparanova V., Kartulev N., Shivachev H. 9-Month-Old Girl with Thoracic Neuroblastoma Encasing the Subclavian Artery, a Case Report. Am J Biomed Sci Res. 2021; 14 (4). AJBSR.MS.ID.002017. doi:10.34297/AJBSR.2021.14.002017.; Koltuksuz U., Gürsoy M. H., Aydinç M., Ozgen U., Ege E., Mutus M. Injuries of large vessels in high stage neuroblastoma surgery. A case report. J Cardiovasc Surg (Torino). 1999; 40 (5): 711–3. PMID: 10597009.; Chong D. S. T., Constantinou J., Davis M., Hamilton G. Calcification of a Synthetic Renovascular Graft in a Child. EJVES Short Rep. 2016; 33: 13–5. doi:10.1016/j.ejvssr.2016.06.001.; Tian W., Fei Y., Liu Z. L., Yao J. Standard resection procedure can increase the complete resection rate in pediatric patients with locally advanced abdominal neuroblastoma. Transl Cancer Res. 2016; 5 (5): 607–12 doi:10.21037/tcr.2016.10.53.; Каприн А. Д. Резекция нижней полой вены при местно-распространенных неорганных забрюшинных опухолях / А. Д. Каприн [и др.] // Онкология. Журнал им. П. А. Герцена. – 2017. – 6 (1): 28–38. doi:10.17116/onkolog20176128-38.; Sutton E. J., Tong R. T., Gillis A. M., Henning T. D., Weinberg V. A., Boddington S., Haas-Kogan D. A., Matthay K., Sha V., Gooding C., Coakley F. V., Daldrup-Link H. Decreased aortic growth and middle aortic syndrome in patients with neuroblastoma after radiation therapy. Pediatr Radiol. 2009; 39: 1194–202. doi:10.1007/s00247-009-1351-1.; Luehr M., Siepe M., Beyersdorf F., Schlensak C. Extra-anatomic bypass for recurrent abdominal aortic and renal in-stent stenoses following radiotherapy for neuroblastoma. Interact Cardiovasc Thorac Surg 2009; 8 (4): 488–90. doi:10.1510/icvts.2008.195230.; Szavay P., Luithle T., Semler O., Graf N., Fuchs J. Surgery of cavoatrial tumor thrombus in nephroblastoma: a report of the SIOP / GPOH study. Pediatr Blood Cancer. 2004; 43 (1): 40–5. doi:10.1002/pbc.20056.; Ахаладзе Д. Г. Тромбоз нижней полой вены и правого предсердия при эмбриональных опухолях у детей / Д. Г. Ахаладзе [и др.] // Вопросы гематологии / онкологии и иммунопатологии в педиатрии. – 2021. – 20 (3): 108–15. doi:10.24287/1726-1708-2021-20-3-108-115.; Murthi G., Kocvildirim E., Sellathury S., Cuckow P. M., Wilcox D. T., Michalski A., Sebire N. J., Elliott M. J., Duffy P. G. Wilms’ tumor with persistent intravascular extension: a review of the surgical aspects of management. J Pediatr Urol. 2006; 2 (5): 439–45. doi:10.1016/j.jpurol.2005.10.004.; Orbach L., Nachmany I., Goykhman Y., Lahat G., Yossepowitch O., Beri A., Ben-Gal Y., Klausner J. M., Lubezky N. Surgical Approach to Abdominal Tumors Involving the Inferior Vena Cava. Isr Med Assoc J. 2020; 22 (6): 364–8. PMID: 32558442.; Shamberger R., Ritchey M., Haase G., Bergemann T., Loechelt-Yoshioka T., Breslow N., Green D. Intravascular Extension of Wilms Tumor. Ann Surg. 2001; 234 (1): 116–21. doi:10.1097/00000658-200107000-00017.; Stanley J. C., Zelenock G. B., Messina L. M., Wakefield T. W. Pediatric renovascular hypertension: a thirty-year experience of operative treatment. J Vasc Surg. 1995; 21 (2): 212–26; discussion 226–7. doi:10.1016/s0741-5214(95)70263-6.; Min S. K., Cho S., Kim H. Y., Kim S. J. Pediatric Vascular Surgery Review with a 30-Year-Experience in a Tertiary Referral Center. Vasc Specialist Int. 2017; 33 (2): 47–54. doi:10.5758/vsi.2017.33.2.47.; Sarti L. Total prosthetic transplantation of the inferior vena cava, with venous drainage restoration of the one remaining kidney on the graft, successfully performed on a child with Wilms’ tumor. Surgery. 1970; 67 (5): 851–5. PMID: 4315277.; Ribeiro R. C., Schettini S. T., de Campos V., Abib S., de Fonseca J. H. P., Cypriano M., da Silva N. S. Cavectomy for the treatment of Wilms tumor with vascular extension. J Urol. 2006; 176 (1): 279–83. doi:10.1016/S0022-5347(06)00561-1.; Angelico R., Passariello A., Pilato M., Cozzolino T., Piazza M., Miraglia R., D’Angelo P., Capasso M., Saffioti M. C., Alberti D., Spada M. Ante situm liver resection with inferior vena cava replacement under hypothermic cardiopolmunary bypass for hepatoblastoma: Report of a case and review of the literature. Int J Surg Case Rep. 2017; 37: 90–6. doi:10.1016/j.ijscr.2017.06.008.; Hort A., Karpelowsky J., Shun A., Thomas G. Use of a donor iliac vein graft for reconstruction of the inferior vena cava in liver transplantation for hepatoblastoma with caval extension. Pediatr Transplant. 2019; 23 (4): e13409. doi:10.1111/petr.13409.; Fuchs J., Cavdar S., Blumenstock G., Ebinger M., Schäfer J. F., Sipos B., Warmann S. W. POST-TEXT III and IV Hepatoblastoma: Extended Hepatic Resection Avoids Liver Transplantation in Selected Cases. Ann Surg. 2017; 266 (2): 318–23. doi:10.1097/SLA.0000000000001936.; Chardot C., Saint Martin C., Gilles A., Brichard B., Janssen M., Sokal E., Clapuyt P., Lerut J., Reding R., Otte J. B. Living-related liver transplantation and vena cava reconstruction after total hepatectomy including the vena cava for hepatoblastoma. Transplantation. 2002; 73 (1): 90–2. doi:10.1097/00007890-200201150-00017.; Baxter B. T., Mahoney C., Johnson P. J., Selmer K. M., Pipinos I. I., Rose J., Neff J. R. Concomitant arterial and venous reconstruction with resection of lower extremity sarcomas. Ann Vasc Surg. 2007; 21 (3): 272–9. doi:10.1016/j.avsg.2007.03.005.; Qureshi S. S., Suresh M., Dhareshwar J., Smriti V. Limb sparing surgery with vascular reconstruction for nonrhabdomyosarcoma soft tissue sarcoma in infants: A novel solution using allogenic vein graft from the parent. J Pediatr Surg. 2020; 55 (8): 1673–6. doi:10.1016/j.jpedsurg.2020.03.029.; https://journal.nodgo.org/jour/article/view/883

الاتاحة: https://journal.nodgo.org/jour/article/view/883
https://doi.org/10.21682/2311-1267-2022-9-4-53-63

المؤلفون: D. O. Kuzmin, V. A. Manukovsky, S. F. Bagnenko, O. N. Reznik, A. N. Ananiev, O. A. Vorobyeva, S. L. Vorobyev, D. V. Gogolev, V. S. Daineko, A. A. Kutenkov, N. A. Chichagova, I. V. Uliankina, Д. О. Кузьмин, В. А. Мануковский, С. Ф. Багненко, О. Н. Резник, А. Н. Ананьев, О. А. Воробьёва, С. Л. Воробьёв, Д. В. Гоголев, В. С. Дайнеко, А. А. Кутенков, Н. А. Чичагова, И. В. Ульянкина

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 24, № 4 (2022); 124-134 ; Вестник трансплантологии и искусственных органов; Том 24, № 4 (2022); 124-134 ; 2412-6160 ; 1995-1191

مصطلحات موضوعية: поликлональные антитела, ischemia-reperfusion injury, polyclonal antibodies, ишемия-реперфузия

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/1544/1395; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1160; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1161; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1162; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1163; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1164; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1165; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1166; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1167; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1168; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1169; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1170; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1171; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1172; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1173; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1174; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1175; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1232; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1233; https://journal.transpl.ru/vtio/article/downloadSuppFile/1544/1234; McFarlane PA. Should patients remain on intensive hemodialysis rather than choosing to receive a kidney transplant? Seminars in Dialysis. 2010; 23: 516–519. doi:10.1111/j.1525-139X.2010.00740.x. PMID: 21039877.; Bahadur MM, Binnani P, Gupta R, Pattewar S. Marginal donor kidney in a marginal recipient: Five year follow-up. Indian J Nephrol. 2010; 20 (2): 100–102. doi:10.4103/0971-4065.65306. PMID: 20835327.; Barba J, Zudaire J, Robles JE, Rosell D, Berian JM, Pascual I. Complications of kidney transplantation with grafts from expanded criteria donors. World J Urol. 2013; 31: 893–899. doi:10.1007/s00345-012-0831-3. PMID: 22290479.; Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation. 1997; 63: 968–974. doi:10.1097/00007890-199704150-00011. PMID: 9112349.; Perico N, Gaspari F, Remuzzi G. Assessing Renal Function by GFR Prediction Equations in Kidney Transplantation. American Journal of Transplantation. 2005; 5: 1175–1176. doi:10.1111/j.1600-6143.2005.00939.x. PMID: 15888019.; De Vries DK, Lindeman JHN, Ringers J, Reinders MEJ, Rabelink TJ, Schaapherder AFM. Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantation. American Journal of Transplantation. 2011; 11 (5): 1064–1070. doi:10.1111/j.1600-6143.2011.03466.x. PMID: 21449948.; Yarlagadda SG, Coca SG, Formica Jr RN, Poggio ED, Parikh CR. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrology Dialysis Transplantation. 2009; 24 (3): 1039–1047. doi:10.1093/ndt/gfn667. PMID: 19103734.; Hashemi P et al. NETosis in ischemic/reperfusion injuries: An organ-based review. Life Sci. 2022; 290: 120158. doi:10.1016/j.lfs.2021.120158. PMID: 34822798.; Cahilog Z et al. The Role of Neutrophil NETosis in Organ Injury: Novel Inflammatory Cell Death Mechanisms. Inflammation. 2020; 43 (6): 2021–2032. doi:10.1007/s10753-020-01294-x. PMID: 32830308.; Nakamura K, Kageyama S, Kupiec-Weglinski JW. Innate immunity in ischemia-reperfusion injury and graft rejection. Curr Opin Organ Transplant. 2019; 24 (6): 687–693. doi:10.1097/MOT.0000000000000709. PMID: 31592839.; Иванов КП, Левкович ЮИ. Изменение микроциркуляции при лейкоцитозе. Физиол журн. 1992; 76: 321–326.; Schofield ZV, Woodruff TM, Halai R, Wu MC, Cooper MA. Neutrophils – a key component of ischemia-reperfusion injury. Shock. 2013; 40 (6): 463–70. doi:10.1097/SHK.0000000000000044. PMID: 24088997.; Liew PX, Kubes P. The neutrophil’s role during health and disease. Physiological reviews. 2019: 99 (2): 1223–1248. doi:10.1152/physrev.00012.2018.; Carbone F, Bonaventura A, Montecucco F. NeutrophilRelated Oxidants Drive Heart and Brain Remodeling After Ischemia/Reperfusion Injury. Front Physiol. 2020; 10: 1587. doi:10.3389/fphys.2019.01587. PMID: 32116732.; Tejchman K et al. The Role of Endothelins, IL-18, and NGAL in Kidney Hypothermic Machine Perfusion. Biomedicines. 2021; 9 (4): 417. doi:10.3390/biomedicines9040417. PMID: 33924469.; Qi H, Yang S, Zhang L. Neutrophil Extracellular Traps and Endothelial Dysfunction in Atherosclerosis and Thrombosis. Front Immunol. 2017; 8: 928. doi:10.3389/fimmu.2017.00928. PMID: 28824648.; Mittal M et al. Neutrophil Activation of Endothelial CellExpressed TRPM2 Mediates Transendothelial Neutrophil Migration and Vascular Injury. Circ Res. 2017; 121 (9): 1081–1091. doi:10.1161/circresaha.117.311747. PMID: 28790198.; Urisono Y et al. Von Willebrand Factor Aggravates Hepatic Ischemia-Reperfusion Injury by Promoting Neutrophil Recruitment in Mice. Thromb Haemost. 2018; 118 (4): 700–708. doi:10.1055/s-0038-1636529. PMID: 29618155.; Fernández AR, Sánchez-Tarjuelo R, Cravedi P, Ochando J, López-Hoyos M. Review: Ischemia Reperfusion Injury-A Translational Perspective in Organ Transplantation. Int J Mol Sci. 2020; 21 (22): 8549. doi:10.3390/ijms21228549. PMID: 33202744.; Trzpis M et al. Expression of EpCAM is up-regulated during regeneration of renal epithelia. J Pathol. 2008; 216 (2): 201–208. doi:10.1002/path.2396. PMID: 18702175.; Akhtar AM et al. In vivo quantification of VCAM-1 expression in renal ischemia reperfusion injury using non-invasive magnetic resonance molecular imaging. PLoS One. 2010; 5 (9): 34–35. doi:10.1371/journal.pone.0012800. PMID: 20877722.; Hanif Z et al. Role of biobanks in transplantation. Annals of medicine and surgery. 2018; 28: 30–33. doi:10.1016/j.amsu.2018.02.007.; https://journal.transpl.ru/vtio/article/view/1544

الاتاحة: https://journal.transpl.ru/vtio/article/view/1544
https://doi.org/10.15825/1995-1191-2022-4-124-134

المؤلفون: I. V. Uliyankina, A. E. Skvortsov, A. N. Ananiev, A. A. Kutenkov, D. O. Kuzmin, V. S. Daineko, D. V. Gogolev, O. N. Reznik, И. В. Ульянкина, А. Е. Скворцов, А. Н. Ананьев, А. А. Кутенков, Д. О. Кузьмин, В. С. Дайнеко, Д. В. Гоголев, О. Н. Резник

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 18, № 4 (2016); 77-86 ; Вестник трансплантологии и искусственных органов; Том 18, № 4 (2016); 77-86 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2016-4

مصطلحات موضوعية: эверолимус, immunosuppressive therapy, calcineurin inhibitors, Cyclosporine, Tacrolimus, Everolimus, иммуносупрессивная терапия, ингибиторы кальциневрина, циклоспорин, такролимус

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/703/593; Nankivell BJ, Borrows RJ, Fung CL et al. The Natural History of Chronic Allograft Nephropathy. N. Engl. J. Med. 2003; 349 (24): 2326–2333.; Naesens M, Kuypers DRJ, Sarwal M et al. Calcineurin Inhibitor Nephrotoxicity. Clin. J. Am. Soc. Nephrol. 2009 Feb; 4 (2): 481–508.; Chapman JR. Chronic Calcineurin Inhibitor Nephrotoxicity – Lest We Forget. Am. J. Transplant. 2011; 11 (4): 693–697.; Nankivell BJ, Wavamunno MD, Borrows RJ et al. Mycophenolate Mofetil Is Associated with Altered Expression of Chronic Renal Transplant Histology. Am. J. Transplant. 2007; 7 (2): 366–376.; Holdaas H, Midtvedt K, Asberget A. A drug safety evaluation of everolimus in kidney transplantation. Expert Opin. Drug. Saf. 2012; 11 (6): 1013–1022.; Brazelton TR, Morris R. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and lefl unomide. Curr. Opin. Immunol. 1996; 8 (5): 710–720.; Grinyo JM, Bestard O, Torras J, Cruzado JM. Optimal immunosuppression to prevent chronic allograft dysfunction. Kidney Int. 2010; 78 (119): 66–70.; Brouard S, Renaudin K, Soulillou JP. Revisiting the natural history of IF/TA in renal transplantation. Am. J. Transplant. 2011; 11: 647–649.; Matas AJ. Chronic progressive calcineurin nephrotoxicity: an overstated concept. Am. J. Transplant. 2011; 11: 687–692.; Tedesco-Silva HJr, Vitko S, Pascual J et al. 12-month safety and effi cacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients. Transpl. Int. 2007; 20 (1): 27–36.; Tedesco-Silva HJr, Cibrikb D, Johnstonc T et al. Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsAin Renal Transplant Recipients. Am. J. Transplant. 2010; 10: 1401–1413.; Cibrik D, Tedesco-Silva JrH, Vathsala A et al. Randomized Trial of Everolimus- Facilitated Calcineurin Inhibitor Minimization Over 24 Months in Renal Transplantation. Transplantation. 2013; 95 (7): 933–942.; Kahan BD, Sheena G, Tejpal N et al. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation. 1991; 51 (1): 232–239.; Резник ОН, Багненко СФ, Мойсюк ЯГ и др. Трансплантация почек от возрастных доноров. Актуальность, первый опыт и перспективы. Вестник трансплантологии и искусственных органов. 2009; 1: 11–22. Reznik ON, Bagnenko SF, Mojsyuk YaG i dr. Transplantaciya pochek ot vozrastnyh donorov. Aktual’nost’, pervyj opyt i perspektivy. Vestnik transplantologii i iskusstvennyh organov. 2009; 1: 11–22.; Cohen B, Smits JM, Haase B et al. Expanding the donor pool to increase renal transplantation. Nephrol. Dial. Transpl. 2005; 20: 34–38.; Meier-Kriesche H, Schold JD, Gaston RS et al. Kidneys from deceased donors: maximizing the value of a scarce resource. Am. J. Тransplant. 2005; 5: 1725–1730.; Nicholson MJ. Renal transplantation from non-heart-beating donors: Opportunities and Challenges. Transplantation Reviews. 2000; 14 (1): 1–17.; Arns W, Citterio F, Campistol JM. «Old-for-old» – new strategies for renal transplantation. Neprol. Dial. Transplant. 2007; 22: 336–341.; Carter JT, Chan S, Roberts JP. Expanded criteria donor kidney allocation: marked decrease in cold ischemia and delayed graft function at a single center. Am. J. Transplant. 2005; 5: 2745–2753.; Danovitch GM, Gaston RS et al. The report of a national conference on the wait list for kidney transplantation. Am. J. Transplant. 2003; 3 (7): 775–785.; Delmonico FL, Wynn JJ. Managing the enlarging waiting list. Am. J. Transplant. 2002; 2: 889–890.; Port F. Expanded criteria donors for kidney transplantation. Am. J. Transplant. 2003; 3 (14): 114–125.; Sung RS, Guidinger MK, Lake CD. Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys. Transplantation. 2005; 79 (9): 1257–1261.; Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialisys, patients on dialisys waiting transplantation and recipients of a fi rst cadaveric transplant. N. Engl. J. Med. 1999; 341: 1725–1729.; Резник ОН, Тутин АП, Ульянкина ИВ. Минимизация иммуносупрессии при трансплантации почки. Вестник трансплантологии и искусственных органов. 2011; XIII (4): 66–75. Reznik ON, Tutin AP, Ul’yankina IV. Minimizaciya immunosupressii pri transplantacii pochki. Vestnik transplantologii i iskusstvennyh organov. 2011; XIII (4): 66–75.; Martins PNA, Pratschke J, Pascher A et al. Age and immune response in organ transplantation. Transplantation. 2005; 79: 127–132.; Matas AJ, Lawson W, McHugh L et al. Employment patterns after successful kidney transplantation. Transplantation. 1996; 61: 729–733.; Meier-Kriesche HU, Ojo A, Hanson J et al. Exponentially insceased risk of infectious death in older transplant recipients. Kidney Int. 2001; 59: 1539.; Li YT, Danguilan RA, Cabanayan-Casasola CB et al. Everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: Philippine experience. Transplantation Proceedings. 2008; 40: 2211–2213.; Luke PPW, Nguan CY, Horovitz D. Immunosupression without calcineurin inhibition: optimization of renal function in expanded criteria donor renal transplantation. Clin. Transplant. 2008; 10: 1–7.; Прокопенко ЕИ. Применение эверолимуса у de novo реципиентов почечного трансплантата. Вестник трансплантологии и искусственных органов. 2010; 2: 74–82. Prokopenko EI. Primenenie ehverolimusa u de novo recipientov pochechnogo transplantata. Vestnik transplantologii i iskusstvennyh organov. 2010; 2: 74–82.; Fellstrom B. Cyclosporinenephrotoxicity. Transplantation Proceedings. 2004; 36: 220–223.; Giron F, Baez Y, Niño-Murcia A et al. Conversion Therapy to Everolimus in Renal Transplant Recipients: Results After One Year. Transplant. Proc. 2008; 40: 711–713.; Inza A, Balda S, Álvarez E et al. Conversion to Everolimus in Kidney Transplant Recipients with Decreased Renal Function. Transplant. Proc. 2009; 41: 2134–2136.; Pascual J. The use of everolimus in renal-transplant patients. International Journal of Nephrology and Renovascular Disease. 2009; 2: 9–21.; Mjornstedta L, Sørensenb SS, von zur Muhlenc B et al. Improved Renal Function after Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation. Am. J. Transplant. 2012; 12 (10): 2744–2753.; Pascual J et al. Everolimus (Certican) in renal transplantation: a review of clinical trial data, current usage, and future directions. Transplantation Reviews. 2006; 20: 1–18.; Pascual J, Srinivas TR, Chadban S et al. TRANSFORM: a novel study design to evaluate the effect of everolimus on long-term outcomes after kidney transplantation. Open Access Journal of Clinical Trials. 2014; 6: 45–54.; Tu Y, Stepkowski SM, Chou TC, Kahan BD. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice. Transplantation. 1995; 59: 177–183.; Morris RE. Rapamycins: antifungal, antitumor, antiproliferative, and immunosuppressive macrolides. Transplant. Rev. 1992; 6: 39–87.; Vitko S, Margreiter R, Weimar W et al. Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients. Am. J. Transplant. 2005; 5: 2521–2530.; Nashan B, Curtis J, Ponticelli C et al. Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: a three-year phase II, randomized, multicenter, open-label study. Transplantation. 2004; 78: 1332–1340.; Lorber MI, Mulgaonkar S, Butt KMH et al. Everolimus versus Mycophenolate Mofetil in the Prevention of Rejection in de novo Renal Transplant Recipients: A 3-year Randomized, Multicenter, Phase III Study. Transplantation. 2005; 80: 244–252.; Sagedal S, Nordal KP, Hartmann A et al. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am. J. Transplant. 2002; 2: 850–856.; Brennan DC, Legendre C, Patel D et al. Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trials. Am. J. Transplant. 2011; 11: 2453–2462.; Langer RM, Hene R, Vitko S et al. Everolimus plus early tacrolimus minimization: a phase III, randomized, openlabel, multicenter trial in renal transplantation. Transpl. Int. 2012; 25: 592–602.; Kovarik JM et al. Differential Pharmacokinetic Interaction of Tacrolimus and Cyclosporine on Everolimus. Transplant. Proc. 2006; 38: 3456–3458.; Schuurman H et al. SDZ RAD, A new rapamycin derivate: Synergism with Cyclosporine. Transplantation. 1997; 64 (1): 32–35.; Abramowicz D et al. Cyclosporine Withdrawal from a Mycophenolate Mofetil – Containing Immunosuppressive Regimen: Results of a Five-Year, Prospective, Randomized Study. J. Am. Soc. Nephrol. 2005; 16: 2234–2240.; https://journal.transpl.ru/vtio/article/view/703

الاتاحة: https://journal.transpl.ru/vtio/article/view/703
https://doi.org/10.15825/1995-1191-2016-4-77-86

المؤلفون: A. E. Skvortsov, I. V. Loginov, A. A. Kukushkin, A. N. Ananiev, A. A. Kutenkov, D. O. Kuzmin, V. S. Daineko, M. Yu. Shiganov, O. N. Reznik, А. Е. Скворцов, И. В. Логинов, А. А. Кукушкин, А. Н. Ананьев, А. А. Кутенков, Д. О. Кузьмин, В. С. Дайнеко, М. Ю. Шиганов, О. Н. Резник

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 18, № 3 (2016); 57-67 ; Вестник трансплантологии и искусственных органов; Том 18, № 3 (2016); 57-67 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2016-3

مصطلحات موضوعية: экстракорпоральная перфузия донорских органов in situ, 60-min asystole, ischemia-reperfusion kidney transplantation, extracorporeal perfusion in situ, 60-минутная асистолия, ишемия-реперфузия, трансплантация почки

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/671/565; Органное донорство и трансплантация в Российской Федерации в 2013 году (VI сообщение национального регистра Российского трансплантологического общества). Трансплантология: итоги и перспективы. Том V. 2013 год / Под ред. С.В. Готье. М.–Тверь: Триада, 2014: 352, 32–57. Organ donation and transplantation in Russian Federation in 2014 (VI report of National Registry). Transplantology: results and prospects. Vol. V. 2013 / ed. by S.V. Gautier. M.–Tver: Triad, 2014: 352, 32–57.; Донорство и трансплантация органов в Российской Федерации в 2014 году (VII сообщение национального регистра Российского трансплантологического общества). Трансплантология: итоги и перспективы. Том VI. 2014 год / Под ред. С.В. Готье. М.– Тверь: Триада, 2015; 488, 44–75. Organ donation and transplantation in Russian Federation in 2015 (VII report of National Registry). Transplantology: results and prospects. Vol. VI. 2014 / ed. by S.V. Gautier. M.–Tver: Triad, 2015: 488, 44–75.; Погребниченко ИВ, Мойсюк ЯГ, Резник ОН. Есть ли законные основания для участия стационаров в программах органного донорства? Здравоохранение. 2012; 1: 40–48. Pogrebnichenko IV, Moysyuk YaG, Reznik ON. Est li zakonnyie osnovaniya dlya uchastiya statsionarov v programmah organnogo donorstva? Zdravoohranenie. 2012; 1: 40–48.; Распоряжение Комитета здравоохранения Санкт- Петербурга № 672-р от 11.08.14 г. «О совершенствовании организации органного донорства в Санкт-Петербурге». Rasporyazheniye Komiteta zdravoohraneniya Sankt-Peterburga № 672-r ot 11.08.14 g. «O sovershenstvovanii organizacii organnogo donorstva v Sankt-Peterburge».; Багненко СФ, Полушин ЮС, Мойсюк ЯГ, Минина МГ, Логинов ИВ, Погребниченко ИВ, Резник ОН. Анализ причин дефицита доноров органов и основные направления его преодоления. Трансплантология. 2011; 2 (3): 10–23. Bagnenko SF, Polushin YuS, Moysyuk YaG, Minina MG, Loginov IV, Pogrebnichenko IV, Reznik ON. Analiz prichin defi tsita donorov organov i osnovnyie napravleniya ego preodoleniya. Transplantologiya. 2011; 2 (3): 10–23.; Багненко СФ, Резник ОН, Мойсюк ЯГ, Погребниченко ИВ. Перспективы развития органного донорства. Здравоохранение. 2011; 11: 40–47. Bagnenko SF, Reznik ON, Moysyuk YaG, Pogrebnichenko IV. Perspektivy razvitiya organnogo donorstva. Zdravoohranenie. 2011; 11: 40–47.; http://www.UNOS.org, доступ 16.03.2016.; http://www.eurotransplant.org/, доступ 16.03.2016.; Багненко СФ, Логинов ИВ, Резник ОН. Причины дефицита донорских органов и пути его преодоления. Медицинский академический журнал. 2011; 4 (11): 13–25. Bagnenko SF, Loginov IV, Reznik ON. Prichiny defi cita donorskih organov i puti ego preodoleniya. Medicinskij akademicheskij zhurnal. 2011; 4 (11): 13–25.; Rozenthal R. Organ Donation: Quo vadis? Annals of Transplantation. 2006; 11 (3): 49–51. 11. Hanto DW, Veatch RM. Uncontrolled donation after circulatory determination of death (UDCDD) and the defi - nition of death. Am. J. Transplant. 2011; 11 (7): 1351– 1352. doi:10.1111/j.1600-6143.2011.03583.x.; Mone TD. The business of organ procurement. Curr. Opinion in Organ Transplant. 2002; 7: 60–64.; van Dijk G, Giezeman A, Ultee F, Hamers R. Organ donation after active euthanasia in a patient with a neurodegenerative disease. Ned Tijdschr Geneeskd. 2013; 157 (39): A6548. PMID: 24063672.; Domínguez-Gil B, Delmonico FL, Faissal AM Shaheen et al. The critical pathway for deceased donation: reportable uniformity in the approach to deceased donation. Transplant International a 2011 European Society for Organ Transplantation. 2011; 24: 373–378.; Domínguez-Gil B, Haase-Kromwijk B, Van Leiden H. Current situation of donation after circulatory death in European countries. Transpl. Int. 2011; 24 (7): 676–686. doi:10.1111/j.1432-2277.2011.01257.x.; Bramhall S. Presumed consent for organ donation: a case against. Ann. R. Coll. Surg. Engl. 2011 May; 93 (4): 270– 272. doi:10.1308/147870811X571136b.; White SL, Leichtman AB, O’Connor K, Lipkowitz G, Pietroski R, Stoff JS et al. Predictors of liver donation without kidney recovery in a cohort of expanded criteria donors: identifying opportunities to improve expanded criteria donor kidney utilization. Transplant Proc. 2012 Sep; 44 (7): 2223–2226. doi:10.1016/j.transproceed.2012.07.103.; Sung RS, Christensen LL, Leichtman AB, Greenstein SM, Distant DA, Wynn JJ et al. Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am. J. Transplant. 2008 Apr; 8 (4): 783–792. doi:10.1111/j.1600-6143.2008.02157.x. Epub 2008 Feb 19.; Manara AR, Murphy PG, O’Callaghan G. Donation after circulatory death. Br. J. Anaesth. 2012; 108 (1): 1108–1121. doi:10.1093/bja/aer357.; Garcia CE, Bramhall S, Mirza DF. Use of marginal donors. Current Opinion in Organ Transplantation. 2000; 5: 50–56.; Reznik ON, Bagnenko SF, Skvortsov AE et al. Rehabilitation of Ischemically Damaged Human Kidneys by Normothermic Extracorporal Hemoperfusion in situ With Oxygenation and Leukocyte Depletion. Transplantation proceedings. 2010; 42 (5): 1536–1538.; Reznik ON, Bagnenko SF, Skvortsov AE. Uncontrolled Donors with Controlled Reperfusion after Sixty Minutes of Asystole: A Novel Reliable Resource for Kidney Transplantation. PloS One. 2013; 8 (5): e64209.; James FC, Catharyn TL. Organ Donation: Opportunities for Action // Institute of Medicine (U.S.). Committee on Increasing Rates of Organ Donation. 2006.; Xu H, Wang D, Peng C, Huang X, Ou M, Wang N et al. Rabbit sera containing compound danshen dripping pill attenuate leukocytes adhesion to TNF-alpha – activated human umbilical vein endothelial cells by suppressing endothelial ICAM-1 and VCAM-1 expression through NF-kappaB signaling pathway. J. Cardiovasc. Pharmacol. 2014 Apr; 63 (4): 323–332. doi:10.1097/ FJC.0000000000000046.; Toledo-Pereyra LH. Leukocyte depletion, ischemic injury, and organ preservation. J. of Surg. Research. 2011; 169 (2): 188–189. doi:10.1016/j.jss.2010.09.048.; Wang X, Xiong M, Zeng Y, Sun X, Gong T, Zhang Z. Mechanistic studies of a novel mycophenolic acid-glucosamine conjugate that attenuates renal ischemia/reperfusion injury in rat. Mol Pharm. 2014 Oct 6; 11 (10): 3503– 3514. doi:10.1021/mp500282g. Epub 2014 Aug 25.; Duehrkop C, Rieben R. Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specifi c complement inhibition. Biochem. Pharmacol. 2014 Mar 1; 88 (1): 12–22. doi:10.1016/j. bcp.2013.12.013. Epub 2013 Dec 30. Review.; Durandy Y. Warm pediatric cardiac surgery: European experience. Asian Cardiovasc. Thorac. Ann. 2010; 18 (4): 386–395. doi:10.1177/0218492310376675.; Fan Y, Zhang AM, Xiao YB. Warm versus cold cardioplegia for heart surgery: a meta-analysis. Eur. J. Cardiothorac. Surg. 2010; 37 (4): 912–919. doi:10.1016/j. ejcts.2009.09.030.; Jacob S, Kallikourdis A, Sellke F. Is blood cardioplegia superior to crystalloid cardioplegia? Interact. Cardiovasc. Thorac. Surg. 2008; 7 (3): 491–498. doi:10.1510/ icvts.2008.178343.; Одинак ММ, Вознюк ИА, Янишевский СН, Голохвастов СЮ, Фокин ВА. Острый церебральный тромбоз – реканализация за пределами окна тромболитической терапии. Дисфункция эндотелия. Патогенетическое значение и методы коррекции; под ред. Н.Н. Петрищева. СПб.: ВМедА, 2007: 121–139. Odinak MM, Voznyuk IA, Yanishevskij SN, Golohvastov SYu, Fokin VA. Ostryj cerebral’nyj tromboz – rekanalizaciya za predelami okna tromboliticheskoj terapii. Disfunkciya ehndoteliya. Patogeneticheskoe znachenie i metody korrekcii; pod red. N.N. Petrishcheva. SPb.: VMedA, 2007: 121– 139.; Одинак ММ, Вознюк ИА, Кузнецов АН, Есипова ОГ. Возможности реопозитивной терапии при острой ишемии головного мозга. Регионарное кровообращение и микроциркуляция. 2003; 2 (1): 21–27. Odinak MM, Voznyuk IA, Kuznecov AN, Esipova OG. Vozmozhnosti reopozitivnoj terapii pri ostroj ishemii golovnogo mozga. Regionarnoe krovoobrashchenie i mikrocirkulyaciya. 2003; 2 (1): 21–27.; https://journal.transpl.ru/vtio/article/view/671

الاتاحة: https://journal.transpl.ru/vtio/article/view/671
https://doi.org/10.15825/1995-1191-2016-3-57-67

المؤلفون: O. N. Reznik, A. N. Ananiev, E. S. Nevirovich, V. S. Daineko, A. E. Skvortsov, A. A. Kutenkov, D. O. Kuzmin, О. Н. Резник, А. Н. Ананьев, Е. С. Невирович, В. С. Дайнеко, А. Е. Скворцов, А. А. Кутенков, Д. О. Кузьмин

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 18, № 3 (2016); 50-56 ; Вестник трансплантологии и искусственных органов; Том 18, № 3 (2016); 50-56 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2016-3

مصطلحات موضوعية: трансплантация почки, autosomal dominant polycystic kidney disease, kidney transplantation, аутосомно-доминантный поликистоз почек

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/670/564; Akoh JA. Current management of autosomal dominant polycystic kidney disease. World J. Nephrol. 2015 Sep 6; 4 (4): 468–479. doi:10.5527/wjn.v4.i4.468.; Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2015 Jul; 88 (1): 17–27. doi:10.1038/ki.2015.59.; Ермоленко ВМ, Батэрдэнэ С. Аутосомно-доминантная поликистозная болезнь почек: новые патогенетические и терапевтические аспекты. Нефрология и диализ. 2008; 10 (2): 111–122. Ermolenko VM, Baterdene S. Autosomal dominant polycystic kidney disease (ADPKD): new pathogenetic and therapeutic approach. Nefrologiya i dializ. 2008; 10 (2): 111–122. [In Russ].; Казимиров ВГ, Бутрин СВ, Сапожников АД. Трансплантация почки у больных с аутосомно-доминан- тным поликистозом почек. Волгоград: Издатель, 2003. 112 с. Ka zi mi rov VG, Butrin SV, Sapozhnikov AD. Transplanta tsi ya pochki u bol’nykh s autosomno-dominantnym po li kis to zom pochek. – Volgograd: Izdatel’, 2003. 112 s. [In Russ].; Кутырина ИМ. Поликистоз почек. Нефрология. Национальное руководство. Ред. Н.А. Мухин. М.: ГЭОТАР-Медиа 2009: 508–512. Kutyrina I.M. Polikistoz pochek. Nefrologiya. Natsional’noe rukovodstvo. Red. N.A. Mukhin. M.: GEOTAR-Media 2009: 508–512. [In Russ].; Chebib FT, Prieto M, Jung Y, Irazabal MV, Kremers WK, Dean PG et al. Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease. Transplant Direct. 2015 Nov 1; 1 (10): e43.; Cristea O, Yanko D, Felbel S, House A, Sener A, Luke PP. Maximal kidney length predicts need for native nephrectomy in ADPKD patients undergoing renal transplantation. Can. Urol. Assoc. J. 2014 Jul; 8 (7–8): 278–282. doi:10.5489/cuaj.2128.; Cohen D, Timsit MO, Chrétien Y, Thiounn N, Vassiliu V, Mamzer MF et al. Place of nephrectomy in patients with autosomal dominant polycystic kidney disease waiting for renal transplantation. Prog. Urol. 2008 Nov; 18 (10): 642–649. doi:10.1016/j.purol.2008.06.004.; Patel MS, Kandula P, Wojciechowski D, Markmann JF, Vagefi PA. Trends in the management and outcomes of kidney transplantation for autosomal dominant polycystic kidney disease. J. Transplant. 2014 (1): 675697. doi:10.1155/2014/675697.; Shumate AM, Bahler CD, Goggins WC, Sharfuddin AA, Sundaram CP. Native Nephrectomy with Renal Transplantation is Associated with a Decrease in Hypertension Medication Requirements for Autosomal Dominant Polycystic Kidney Disease. J. Urol. 2016 Jan; 195 (1): 141–146. doi:10.1016/j.juro.2015.07.114.; Binsaleh S, Luke PP, Nguan C, Kapoor A. Comparison of laparoscopic and open nephrectomy for adult polycystic kidney disease: operative challenges and technique. Can. J. Urol. 2006 Dec; 13 (6): 3340–3345.; Bansal RK, Kapoor А. Laparoscopic nephrectomy for massive polycystic kidney disease: Updated technique and outcomes. Can. Urol. Assoc J. 2014 Sep-Oct; 8 (9– 10): 341–345. doi:10.5489/cuaj.2097.; Eng M, Jones CM, Cannon RM, Marvin MR. Hand-assisted laparoscopic nephrectomy for polycystic kidney disease. JSLS. 2013 Apr-Jun; 17 (2): 279–284. doi: 10.4 293/108680813X13654754535719.; Verhoest G, Delreux A, Mathieu R, Patard J, Vigneau C, Rioux-Leclercq N et al. Transperitoneal Laparoscopic Nephrectomy for Autosomal Dominant Polycystic Kidney Disease. JSLS. 2012 Jul-Sep; 16 (3): 437–442. doi:10.4293/108680812X13462882736; Трушкин РН, Лубенников АЕ, Сысоев АМ, Соколов АА. Нефрэктомия у больных с терминальной стадией хронической почечной недостаточности и активным течением пиелонефрита. Экспериментальная и клиническая урология. 2015; 4: 104–109. Trushkin RN, Lubennikov AE, Sysoev AM, Sokolov AA. Nefrektomiya u bol’nykh s terminal’noy stadiey khronicheskoy pochechnoy nedostatochnosti i aktivnym techeniem pielonefrita. Eksperimental’naya i klinicheskaya urologiya. 2015; 4: 104–109.; https://journal.transpl.ru/vtio/article/view/670

الاتاحة: https://journal.transpl.ru/vtio/article/view/670
https://doi.org/10.15825/1995-1191-2016-3-50-56